Parkinson's Disease (PD) is a progressive neurological disorder that affects movement, muscle control, and balance. It is caused by the death of dopamine-producing neurons in the brain, leading to a decrease in dopamine levels. Symptoms of PD include tremors, stiffness, slowness of movement, and impaired balance. Treatment for PD includes medications, physical therapy, and surgery. The PD market within the context of Neurology is a rapidly growing field, with a focus on developing treatments that can improve the quality of life for those living with the disease. Companies in this market are researching and developing new therapies, such as gene therapy, stem cell therapy, and deep brain stimulation, as well as developing new drugs to treat the symptoms of PD. Some companies in the PD market include AbbVie, Acorda Therapeutics, Allergan, Biogen, and Teva Pharmaceuticals. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
